WallStreetZenWallStreetZen

NASDAQ: REVB
Revelation Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Revelation Biosciences earnings were -$14.1M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest REVB earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$4.7M, down 16.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, REVB reported annual earnings of -$15.0M, with 12,405.6% growth.

REVB past earnings growth

How has REVB's earnings growth performed historically?

Company
N/A
Industry
64.44%
Market
55.73%
REVB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
REVB's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

REVB earnings history

Current Revenue
$0.0
Current Earnings
-$14.1M
Current Profit Margin
0%

REVB Return on Equity

Current Company
-251.2%
Current Industry
-19.7%
Current Market
32.1%
REVB's Return on Equity (-251.2%)... subscribe to Premium to read more.
High Return on Equity Performance

REVB undefined

Current Company
-195.3%
Current Industry
-7.7%
REVB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when REVB announces earnings.

REVB undefined

Current Company
-73.88%
Current Industry
-2%
REVB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

REVB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
REVB-$8.10M-$14.08M-99.97%$75.92
CYCN-$2.20M-$2.20MN/A-$0.75
KTTA-$12.81M-$13.46MN/A-$7.55
TCRT-$3.99M-$3.99MN/A-$2.46
ASBP-$17.99M-$18.90MN/A-$0.13
View Top Biotech Stocks

Revelation Biosciences Earnings Reports & History FAQ

What were Revelation Biosciences's earnings last quarter?

Revelation Biosciences (NASDAQ: REVB) reported Q3 2025 earnings per share (EPS) of -$1.77, up 95.59% year over year. Total REVB earnings for the quarter were -$4.68 million. In the same quarter last year, Revelation Biosciences's earnings per share (EPS) was -$40.15.

If you're new to stock investing, here's how to buy Revelation Biosciences stock.

Is Revelation Biosciences profitable or losing money?

As of the last Revelation Biosciences earnings report, Revelation Biosciences is currently losing money. Revelation Biosciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$8.13 million, a 47.61% decrease year over year.

What was REVB's earnings growth in the past year?

As of Revelation Biosciences's earnings date in Q4 2025, Revelation Biosciences's earnings has grown year over year. REVB earnings in the past year totalled -$14.08 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.